Theravance Biopharma, Inc. (TBPH)

19.02 -0.02 (-0.11%) USD  |  NASDAQ  |  Jan 12, 12:00
More

Theravance Biopharma Normalized Basic EPS (Quarterly)

Normalized Basic EPS (Quarterly) Chart

View Normalized Basic EPS (Quarterly) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Normalized Basic EPS (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Normalized Basic EPS (Quarterly) Range, Past 5 Years

View Normalized Basic EPS (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Normalized Basic EPS (Quarterly) Benchmarks

View Normalized Basic EPS (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Skye Bioscience, Inc. Upgrade
Kyntra Bio, Inc. Upgrade
Myomo, Inc. Upgrade